
|Videos|June 26, 2020
Clinical Ramifications of Pneumococcal Vaccine Development
Author(s)Contagion® Editorial Staff
Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Advertisement
Segment Description: Dr. Luwy Musey, executive director in biologics, vaccine clinical research, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Part 1: Developments in Pneumococcal Conjugate Vaccines
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Interpreting FDA’s Request for Warning Labels on Influenza Vaccines About Febrile Seizures
2
Measles Update: January 30, 2026
3
HIV Spending for Fiscal Year 2026: The Latest Update
4
FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease
5

































































































































